Tandem Diabetes Care, Inc. Proceeds from Notes Payable
Tandem Diabetes Care, Inc. (TNDM) reported Proceeds from Notes Payable of $49.99 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2019-02-26
- Tandem Diabetes Care, Inc. proceeds from notes payable for the quarter ending 2016-12-31 was $35.00M.
- Tandem Diabetes Care, Inc. proceeds from notes payable for the quarter ending 2016-09-30 was $0.00.
- Tandem Diabetes Care, Inc. proceeds from notes payable for the quarter ending 2016-06-30 was $0.00.
- Tandem Diabetes Care, Inc. proceeds from notes payable for the quarter ending 2016-03-31 was $14.99M.
- Tandem Diabetes Care, Inc. proceeds from notes payable for fiscal 2016 was $49.99M.
- Tandem Diabetes Care, Inc. proceeds from notes payable for fiscal 2014 was $29.93M, a 3.64% increase from fiscal 2013.
- Tandem Diabetes Care, Inc. proceeds from notes payable for fiscal 2013 was $28.87M, a 477.48% increase from fiscal 2012.
- Tandem Diabetes Care, Inc. proceeds from notes payable for fiscal 2012 was $5.00M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2016-12-31 | $35.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $35.00M derived: sum of 2 quarters · filed 2019-02-26 | $35.00M derived: sum of 3 quarters · filed 2019-02-26 | $49.99M 10-K · filed 2019-02-26 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $0.00 derived: sum of 2 quarters · filed 2017-10-26 | $14.99M 10-Q · filed 2017-10-26 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $14.99M 10-Q · filed 2017-07-27 | ||
| 2016-03-31 | $14.99M 10-Q · filed 2017-04-27 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $0.00 derived: sum of 2 quarters · filed 2017-03-08 | $29.93M 10-K · filed 2017-03-08 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $29.93M 10-Q · filed 2015-10-29 | ||
| 2014-06-30 | $29.93M 10-Q · filed 2015-07-30 | |||
| 2013-12-31 | -$504.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$375.05K derived: sum of 2 quarters · filed 2016-02-24 | -$505.00 derived: sum of 3 quarters · filed 2016-02-24 | $28.87M 10-K · filed 2016-02-24 |
| 2013-09-30 | -$374.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$1.00 derived: sum of 2 quarters · filed 2014-11-06 | $28.87M 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $374.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $29.25M 10-Q · filed 2014-07-31 | ||
| 2013-03-31 | $28.87M 10-Q · filed 2014-05-06 | |||
| 2012-12-31 | $5.00M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |